Peter Mansell reports on how compliance and personal monitoring technologies can help pharma firms better tailor their offerings to different patient groups.

New technology is the lifeblood of drug development. But there is also a parallel stream of technological innovation that addresses how drugs are taken, managed, and monitored in the marketplace. These technologies range from enhanced packaging and reminder messaging (MedivoxRx Technologies' Talking Prescription Bottle) to texts and e-mails to monitoring systems (Johnson & Johnson/Apple's Lifescan application for glucometer data) to 'smart' pills (from Proteus/Novartis) that keep tabs on a patient's response to therapy within the patient's own body.

These technologies are now being applied to address the long-standing compliance problem. Only around one-third of medicines are taken as intended, and this issue has taken on new urgency in light of cost pressures on healthcare systems and trends such as ageing, multiple drug regimens, and chronic disease management.

Full article.

eyeforpharma's 7th Annual Patient Adherence & Engagement Summit, (October 19-20, Philadelphia) will have an entire session on developments in patient relationship marketing and technology innovation. To find out more about the conference and to register to attend, visit: http://www.eyeforpharma.com/pcusa

Source: eyeforpharma